B. Riley Securities Maintains Buy on ClearPoint Neuro, Raises Price Target to $20

B. Riley Securities analyst Neil Chatterji has maintained a Buy rating on ClearPoint Neuro (NASDAQ: CLPT) and increased the price target from $18 to $20. This adjustment reflects a positive outlook for the company's stock performance.